We have detected that OTUD6B-AS1 expression was much higher in CDDP-resistant cervical cancer cells than the parent cells, suggesting the possibility that a high level of OTUD6B-AS1 might be a predictive biomarker for CDDP resistance, and a potential therapeutic target for cervical cancer. This evidence concerns the gene OTUD6B and cervical carcinoma.